MedTrace Logo

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma

NCT03222635 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2024-07-24

No results posted yet for this study

Summary

Aim of this prospective multicenter study is to evaluate the safety of an endoscopic follow-up strategy in patients treated with endoscopic resection (ER) for submucosal or high-risk mucosal esophageal adenocarcinoma (T1bN0M0 or HR T1aN0M0 EAC).

Conditions

  • Submucosal Esophageal Adenocarcinoma
  • Barrett Esophagus
  • High-risk Mucosal Esophageal Adenocarcinoma

Interventions

PROCEDURE

Endoscopic follow-up

Endoscopic follow-up by means of regular upper endoscopies and endoscopic ultrasounds

Sponsors & Collaborators

  • Amsterdam UMC

    lead OTHER

Principal Investigators

  • J. J. Bergman, MD, PhD · Amsterdam UMC

  • R. E. Pouw, MD, PhD · Amsterdam UMC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-25
Primary Completion
2028-07-25
Completion
2028-07-25

Countries

  • Australia
  • Belgium
  • Germany
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03222635 on ClinicalTrials.gov